General Information:

Id: 3,646 (click here to show other Interactions for entry)
Diseases: Diabetes mellitus, type II - [OMIM]
Fatty liver disease, nonalcoholic
Insulin resistance
Reference: Fuchs M(2012) Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target J Lipids 2012 [PMID: 22187656]

Interaction Information:

Comment Another effect of FXR activation is the induction of peroxisome proliferator-activated receptor alpha that promotes fatty acid beta-oxidation.
Formal Description
Interaction-ID: 34644



increases_activity of

Drugbank entries Show/Hide entries for PPARA